204
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Prevalence and Causes of Visual Impairment and Blindness in Elderly Population; an Urgent Geriatric Health Issue: Tehran Geriatric Eye Study (TGES)

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 249-259 | Received 11 Mar 2022, Accepted 30 May 2022, Published online: 07 Jun 2022

References

  • Blindness GBD, Vision Impairment C; Vision Loss Expert Group of the Global Burden of Disease S. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e130–e143. doi:10.1016/S2214-109X(20)30425-3.
  • Pararajasegaram R. VISION 2020-the right to sight: from strategies to action. Am J Ophthalmol. 1999;128(3):359–360. doi:10.1016/s0002-9394(99)00251-2.
  • Blindness GBD, Vision Impairment C; Vision Loss Expert Group of the Global Burden of Disease S. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144–e160. doi:10.1016/S2214-109X(20)30489-7.
  • Emamian MH, Zeraati H, Majdzadeh R, Shariati M, Hashemi H, Fotouhi A. The gap of visual impairment between economic groups in Shahroud, Iran: a Blinder-Oaxaca decomposition. Am J Epidemiol. 2011;173(12):1463–1467. doi:10.1093/aje/kwr050.
  • Zarei E, Pakzad R, Yekta A, Amini M, Sardari S, Khabazkhoob M. Economic Inequality in Visual Impairment: a Study in Deprived Rural Population of Iran. J Curr Ophthalmol. 2021;33(2):165–170. doi:10.4103/2452-2325.288936.
  • Hashemi H, Pakzad R, Yekta A, Aghamirsalim M, Ostadimoghaddam H, Khabazkhoob M. Investigation of Economic Inequality in Eye Care Services Utilization and Its Determinants in Rural Regions Using the Oaxaca- Blinder Decomposition Approach. Semin Ophthalmol. 2021;36(5–6):373–378. doi:10.1080/08820538.2021.1890782.
  • Katibeh M, Sabbaghi H, Kalantarion M, et al. Eye Care Utilization in A Community-oriented Mobile Screening Programme for Improving Eye Health in Iran: a Cluster Randomized Trial. Ophthalmic Epidemiol. 2020;27(6):417–428. doi:10.1080/09286586.2020.1768552.
  • Livingston PM, McCarty CA, Taylor HR. Visual impairment and socioeconomic factors. Br J Ophthalmol. 1997;81(7):574–577. doi:10.1136/bjo.81.7.574.
  • Thevi T, Basri M, Reddy S. Prevalence of eye diseases and visual impairment among the rural population - a case study of Temerloh hospital. Malays Fam Physician. 2012;7:6–10.
  • Vitale S, Cotch MF, Sperduto RD. Prevalence of visual impairment in the United States. JAMA. 2006;295:2158–2163. doi:10.1001/jama.295.18.2158.
  • Elsman EBM, van Rens G, van Nispen RMA. Quality of life and participation of young adults with a visual impairment aged 18–25 years: comparison with population norms. Acta Ophthalmol. 2019;97(2):165–172. doi:10.1111/aos.13903.
  • Briesen S, Roberts H, Finger RP. The impact of visual impairment on health-related quality of life in rural Africa. Ophthalmic Epidemiol. 2014;21(5):297–306. doi:10.3109/09286586.2014.950281.
  • Whitson HE, Cousins SW, Burchett BM, Hybels CF, Pieper CF, Cohen HJ. The combined effect of visual impairment and cognitive impairment on disability in older people. J Am Geriatr Soc. 2007;55(6):885–891. doi:10.1111/j.1532-5415.2007.01093.x.
  • Ng Yin Ling C, Seshasai S, Chee ML, et al. Visual Impairment, Major Eye Diseases, and Mortality in a Multi-Ethnic Asian Population and a Meta-analysis of Prospective Studies. Am J Ophthalmol. 2021;231:88–100. doi:10.1016/j.ajo.2021.04.026.
  • United Nations Department of Economic and Social Affairs. PDWPAHLaoopSESA.
  • Eckert KA, Carter MJ, Lansingh VC, et al. A Simple Method for Estimating the Economic Cost of Productivity Loss Due to Blindness and Moderate to Severe Visual Impairment. Ophthalmic Epidemiol. 2015;22(5):349–355. doi:10.3109/09286586.2015.1066394.
  • Gunnlaugsdottir E, Arnarsson A, Jonasson F. Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study. Acta Ophthalmol. 2008;86(7):778–785. doi:10.1111/j.1755-3768.2008.01191.x.
  • Xu L, Cui T, Yang H, et al. Prevalence of visual impairment among adults in China: the Beijing Eye Study. Am J Ophthalmol. 2006;141(3):591–593. doi:10.1016/j.ajo.2005.10.018.
  • Al-Shaaln FF, Bakrman MA, Ibrahim AM, Aljoudi AS. Prevalence and causes of visual impairment among Saudi adults attending primary health care centers in northern Saudi Arabia. Ann Saudi Med. 2011;31(5):473–480. doi:10.4103/0256-4947.84624.
  • Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116(5):653–658. doi:10.1001/archopht.116.5.653.
  • Araújo Filho A, Salomão SR, Berezovsky A, et al. Prevalence of visual impairment, blindness, ocular disorders and cataract surgery outcomes in low-income elderly from a metropolitan region of São Paulo-Brazil. Arq Bras Oftalmol. 2008;71(2):246–253. doi:10.1590/S0004-27492008000200021.
  • Casson R, Giles L, Newland HS. Prevalence of blindness and visual impairment in an elderly urban population. Aust N Z J Ophthalmol. 1996;24(3):239–243. doi:10.1111/j.1442-9071.1996.tb01586.x.
  • Thapa R, Bajimaya S, Paudyal G, et al. Prevalence and causes of low vision and blindness in an elderly population in Nepal: the Bhaktapur retina study. BMC Ophthalmol. 2018;18(1):42. doi:10.1186/s12886-018-0710-9.
  • Athanasiov PA, Casson RJ, Sullivan T, et al. Cataract in rural Myanmar: prevalence and risk factors from the Meiktila Eye Study. Br J Ophthalmol. 2008;92(9):1169–1174. doi:10.1136/bjo.2008.139725.
  • Evans JR, Fletcher AE, Wormald RP, et al. Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol. 2002;86(7):795–800. doi:10.1136/bjo.86.7.795.
  • Fotouhi A, Hashemi H, Mohammad K, Jalali KH, Tehran Eye S. The prevalence and causes of visual impairment in Tehran: the Tehran Eye Study. Br J Ophthalmol. 2004;88(6):740–745. doi:10.1136/bjo.2003.031153.
  • Michon JJ, Lau J, Chan WS, Ellwein LB. Prevalence of visual impairment, blindness, and cataract surgery in the Hong Kong elderly. Br J Ophthalmol. 2002;86(2):133–139. doi:10.1136/bjo.86.2.133.
  • Wang JJ, Foran S, Mitchell P. Age‐specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Exp Ophthalmol. 2000;28(4):268–273. doi:10.1046/j.1442-9071.2000.00315.x.
  • Sainz-Gómez C, Fernández-Robredo P, Salinas-Alamán Á, et al. Prevalence and causes of bilateral blindness and visual impairment among institutionalized elderly people in Pamplona, Spain. Eur J Ophthalmol. 2010;20(2):442–450. doi:10.1177/112067211002000228.
  • Ponte F, Giuffre G, Giammanco R. Prevalence and causes of blindness and low vision in the Casteldaccia Eye Study. Graefes Arch Clin Exp Ophthalmol. 1994;232(8):469–472. doi:10.1007/BF00195355.
  • Kyari F, Gudlavalleti MV, Sivsubramaniam S, et al. Prevalence of blindness and visual impairment in Nigeria: the national blindness and visual impairment survey. Invest Ophthalmol Vis Sci. 2009;50(5):2033–2039. doi:10.1167/iovs.08-3133.
  • Hashemi H, Shafaee S, Norouzirad R, Mohazzab-Torabi S. Prevalence and causes of visual impairment among the elderly of Sari, 2011. J Curr Ophthalmol. 2013;25:262.
  • Nuertey BD, Amissah-Arthur KN, Addai J, et al. Prevalence, Causes, and Factors Associated with Visual Impairment and Blindness among Registered Pensioners in Ghana. J Ophthalmol. 2019;2019:1–10. doi:10.1155/2019/1717464.
  • Chen N, Huang TL, Tsai RK, Sheu MM. Prevalence and causes of visual impairment in elderly Amis aborigines in Eastern Taiwan (the Amis Eye Study). Jpn J Ophthalmol. 2012;56(6):624–630. doi:10.1007/s10384-012-0178-8.
  • Wang W-L, Chen N, Sheu -M-M, Wang J-H, Hsu W-L, Hu Y-J. The prevalence and risk factors of visual impairment among the elderly in Eastern Taiwan. Kaohsiung J Med Sci. 2016;32(9):475–481. doi:10.1016/j.kjms.2016.07.009.
  • Yamada M, Hiratsuka Y, Roberts CB, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol. 2010;17(1):50–57. doi:10.3109/09286580903450346.
  • Cheng JW, Cheng SW, Cai JP, Li Y, Wei RL. The prevalence of visual impairment in older adults in mainland China: a systematic review and meta-analysis. Ophthalmic Res. 2013;49(1):1–10. doi:10.1159/000327144.
  • Buch H, Vinding T, La Cour M, Appleyard M, Jensen GB, Nielsen NV. Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology. 2004;111(1):53–61. doi:10.1016/j.ophtha.2003.05.010.
  • Buch H, Vinding T, Nielsen NV. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology. 2001;108(12):2347–2357. doi:10.1016/S0161-6420(01)00823-5.
  • Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2004;111(1):62–69. doi:10.1016/j.ophtha.2003.05.011.
  • Tang Y, Wang X, Wang J, et al. Prevalence and Causes of Visual Impairment in a Chinese Adult Population: the Taizhou Eye Study. Ophthalmology. 2015;122(7):1480–1488. doi:10.1016/j.ophtha.2015.03.022.
  • Zhao J, Ellwein LB, Cui H, et al. Prevalence of vision impairment in older adults in rural China: the China Nine-Province Survey. Ophthalmology. 2010;117(3):409–416, 416 e401. doi:10.1016/j.ophtha.2009.11.023.
  • Zheng Y, Lavanya R, Wu R, et al. Prevalence and causes of visual impairment and blindness in an urban Indian population: the Singapore Indian Eye Study. Ophthalmology. 2011;118(9):1798–1804. doi:10.1016/j.ophtha.2011.02.014.
  • Hashemi H, Pakzad R, Aghamirsalim M, et al. Age- and Sex-Standardized Prevalence of Age-Related Cataract and Its Determinants; Tehran Geriatric Eye Study (TGES). Ophthalmic Epidemiol. 2021;1–12. doi:10.1080/09286586.2021.1976804.
  • Hashemi H, Khabazkhoob M, Emamian MH, Shariati M, Fotouhi A. Visual impairment in the 40-To 64-Year-Old population of Shahroud, Iran. Eye (Basingstoke). 2012;26:1071–1077.
  • Hashemi H, Yekta A, Jafarzadehpur E, Doostdar A, Ostadimoghaddam H, Khabazkhoob M. The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future. Eye (Basingstoke). 2017;31:1221–1228.
  • Foster PJ, Buhrmann R, Quigley HA, et al. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238–242. doi:10.1136/bjo.86.2.238.
  • Adegbehingbe B, Fajemilehin B, Ojofeitimi E, Bisiriyu L. Blindness and visual impairment among the elderly in Ife-Ijesha zone of Osun State, Nigeria. Indian J Ophthalmol. 2006;54(1):59. doi:10.4103/0301-4738.21620.
  • Wormald RP, Wright LA, Courtney P, Beaumont B, Haines AP. Visual problems in the elderly population and implications for services. BMJ. 1992;304(6836):1226–1229. doi:10.1136/bmj.304.6836.1226.
  • DiNuzzo AR, Black SA, Lichtenstein MJ, Markides KS. Prevalance of functional blindness, visual impairment, and related functional deficits among elderly Mexican Americans. J Gerontol A Biol Sci Med Sci. 2001;56(9):M548–M551. doi:10.1093/gerona/56.9.M548.
  • Garap JN, Sheeladevi S, Shamanna BR, Nirmalan PK, Brian G, Williams C. Blindness and vision impairment in the elderly of Papua New Guinea. Clin Exp Ophthalmol. 2006;34(4):335–341. doi:10.1111/j.1442-9071.2006.01219.x.
  • Murthy GV, Vashist P, John N, Pokharel G, Ellwein LB. Prevelence and causes of visual impairment and blindness in older adults in an area of India with a high cataract surgical rate. Ophthalmic Epidemiol. 2010;17(4):185–195. doi:10.3109/09286586.2010.483751.
  • Larsen PP, Thiele S, Krohne TU, et al. Visual impairment and blindness in institutionalized elderly in Germany. Graefes Arch Clin Exp Ophthalmol. 2019;257(2):363–370. doi:10.1007/s00417-018-4196-1.
  • Gunnlaugsdottir E, Arnarsson AM, Jonasson F. Visual impairment and blindness in Icelanders aged 50 years and older-the Reykjavik Eye Study. Laeknabladid. 2013;99(3):123–127. doi:10.17992/lbl.2013.03.486.
  • Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol. 1990;108(2):286–290. doi:10.1001/archopht.1990.01070040138048.
  • Rubin GS, West SK, Munoz B, et al. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci. 1997;38:557–568.
  • Taylor HR, Livingston PM, Stanislavsky YL, McCarty CA. Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project. Am J Ophthalmol. 1997;123(3):328–337. doi:10.1016/S0002-9394(14)70128-X.
  • Munoz B, West SK, Rubin GS, et al. Causes of Blindness and Visual Impairment in a Population of Older Americans The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118(6):819–825. doi:10.1001/archopht.118.6.819.
  • Esteban JJ, Martinez MS, Navalon PG, et al. Visual impairment and quality of life: gender differences in the elderly in Cuenca, Spain. Qual Life Res. 2008;17(1):37–45. doi:10.1007/s11136-007-9280-7.
  • Lansingh VC, Resnikoff S, Tingley-Kelley K, et al. Cataract surgery rates in latin america: a four-year longitudinal study of 19 countries. Ophthalmic Epidemiol. 2010;17(2):75–81. doi:10.3109/09286581003624962.
  • HASHEMI H, REZVAN F, YEKTA A, et al. The Prevalence and Causes of Visaual Impairment and Blindness in a Rural Population in the North of Iran. Iran J Public Health. 2015;44(6):855–864.
  • Seah SK, Wong TY, Foster PJ, Ng TP, Johnson GJ. Prevalence of lens opacity in Chinese residents of Singapore: the tanjong pagar survey. Ophthalmology. 2002;109(11):2058–2064. doi:10.1016/S0161-6420(02)01221-6.
  • Rosenblatt TR, Vail D, Saroj N, Boucher N, Moshfeghi DM, Moshfeghi AA. Increasing Incidence and Prevalence of Common Retinal Diseases in Retina Practices Across the United States. Ophthalmic Surg Lasers Imaging Retina. 2021;52(1):29–36. doi:10.3928/23258160-20201223-06.
  • McWilliams JM, Zaslavsky AM, Meara E, Ayanian JZ. Health insurance coverage and mortality among the near-elderly. Health Affairs. 2004;23(4):223–233. doi:10.1377/hlthaff.23.4.223.
  • Hashemi H, Rezvan F, Pakzad R, et al. Global and Regional Prevalence of Diabetic Retinopathy; A Comprehensive Systematic Review and Meta-analysis. Semin Ophthalmol. 2022;37(3). 2022;291–306.
  • Maseko SN, van Staden D, Mhlongo EM. The Rising Burden of Diabetes-Related Blindness: a Case for Integration of Primary Eye Care into Primary Health Care in Eswatini. Healthcare (Basel, Switzerland). 2021; 9(7): doi: 10.3390/healthcare9070835.
  • Kuper H, Polack S, Eusebio C, Mathenge W, Wadud Z, Foster A. A case-control study to assess the relationship between poverty and visual impairment from cataract in Kenya, the Philippines, and Bangladesh. PLoS Med. 2008;5(12):e244. doi:10.1371/journal.pmed.0050244.
  • Gilbert CE, Shah SP, Jadoon MZ, et al. Poverty and blindness in Pakistan: results from the Pakistan national blindness and visual impairment survey. BMJ. 2008;336(7634):29–32. doi:10.1136/bmj.39395.500046.AE.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.